Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Healthcare (NHC)

National HealthCare Reports 2024 Revenue of $1.31 Billion, Up 14.5% From 2023

Mixed Impact 3 of 5 earnings Written later

National HealthCare reported full-year 2024 net operating revenues and grant income of $1,307,382,000, up 14.5% from 2023, and GAAP net income attributable to NHC of $101,927,000, up from $66,798,000. Fourth-quarter GAAP net income fell to $6,081,000 from $28,406,000, mainly due to an unrealized loss of $25,332,000 on marketable equity securities, while adjusted net income rose 62.7% to $25,954,000.

Key points

  • Full-year 2024 GAAP diluted EPS was $6.53, compared with $4.34 in 2023; adjusted diluted EPS was $4.93, compared with $3.55.
  • Fourth-quarter 2024 GAAP diluted EPS was $0.39, compared with $1.83 in the fourth quarter of 2023; adjusted diluted EPS was $1.66, compared with $1.03.
  • Full-year revenue growth reflected a 9.4% increase in same-facility net operating revenues and the August 1, 2024 acquisition of White Oak Manor.
  • The filing does not include forward-looking guidance for 2025; the full press release is attached as Exhibit 99.1.

The filing

CompanyNational Healthcare (NHC)
Form8-K, current report
Filed with the SECFeb 27, 2025, 5:13 PM ET
Accession number0001437749-25-005510

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.